Clinical Trial Update: Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the combination of dabrafenib and trametinib after radiation therapy for newly diagnosed high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ganglioglioma
• Anaplastic Pleomorphic Xanthoastrocytoma
• Glioblastoma
• High-grade Glioma
• Malignant Glioma
• Who Glioma

Drugs mentioned

• Dabrafenib (Dabrafenib)
• Trametinib (trametinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified | Phase 2 | Status: ACTIVE_NOT_RECRUITING